Cover Image
市場調查報告書

Northwest Biotherapeutics, Inc.- 產品平台檢討

Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 200980
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Northwest Biotherapeutics, Inc.- 產品平台檢討 Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014
出版日期: 2014年05月30日 內容資訊: 英文 33 Pages
簡介

Northwest Biotherapeutics, Inc. (NW Bio) 是開發階段的生物科技企業,從事免疫疾病療法用新醫藥品之開發。致力於開發對治療癌症有效,卻不像一般化療一樣具有副作用的治療藥。

本報告提供Northwest Biotherapeutics, Inc.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Northwest Biotherapeutics, Inc.的基本資料

Northwest Biotherapeutics, Inc.概要

  • 主要資訊
  • 企業資料

Northwest Biotherapeutics, Inc.:R&D概要

  • 主要的治療範圍

Northwest Biotherapeutics, Inc.:開發平台(管線)的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Northwest Biotherapeutics, Inc.:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Northwest Biotherapeutics, Inc.:藥物簡介

  • DCVax-L Vaccine
  • DCVax-Prostate
  • DCVax-Direct
  • CXCR4 Antibody

Northwest Biotherapeutics, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Northwest Biotherapeutics, Inc.:最近的開發平台趨勢

Northwest Biotherapeutics, Inc.:企業發表

Northwest Biotherapeutics, Inc.:總公司和子公司的所地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05058CDB

Global Markets Direct's, 'Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Northwest Biotherapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Northwest Biotherapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Northwest Biotherapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Northwest Biotherapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Northwest Biotherapeutics, Inc.'s pipeline products

Reasons to buy

  • Evaluate Northwest Biotherapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Northwest Biotherapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Northwest Biotherapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Northwest Biotherapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northwest Biotherapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Northwest Biotherapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Northwest Biotherapeutics, Inc. Snapshot
    • Northwest Biotherapeutics, Inc. Overview
    • Key Information
    • Key Facts
  • Northwest Biotherapeutics, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Northwest Biotherapeutics, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Northwest Biotherapeutics, Inc. - Pipeline Products Glance
    • Northwest Biotherapeutics, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Northwest Biotherapeutics, Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Northwest Biotherapeutics, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Northwest Biotherapeutics, Inc. - Drug Profiles
    • DCVax-L Vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DCVax-Prostate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • DCVax-Direct
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CXCR4 Antibody
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Northwest Biotherapeutics, Inc. - Pipeline Analysis
    • Northwest Biotherapeutics, Inc. - Pipeline Products by Target
    • Northwest Biotherapeutics, Inc. - Pipeline Products by Route of Administration
    • Northwest Biotherapeutics, Inc. - Pipeline Products by Molecule Type
    • Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action
  • Northwest Biotherapeutics, Inc. - Recent Pipeline Updates
  • Northwest Biotherapeutics, Inc. - Company Statement
  • Northwest Biotherapeutics, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Northwest Biotherapeutics, Inc., Key Information
  • Northwest Biotherapeutics, Inc., Key Facts
  • Northwest Biotherapeutics, Inc. - Pipeline by Indication, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Stage of Development, 2014
  • Northwest Biotherapeutics, Inc. - Monotherapy Products in Pipeline, 2014
  • Northwest Biotherapeutics, Inc. - Phase III, 2014
  • Northwest Biotherapeutics, Inc. - Phase I, 2014
  • Northwest Biotherapeutics, Inc. - Preclinical, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Target, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Route of Administration, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Molecule Type, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014
  • Northwest Biotherapeutics, Inc. - Recent Pipeline Updates, 2014
  • Northwest Biotherapeutics, Inc., Subsidiaries

List of Figures

  • Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Indication, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Stage of Development, 2014
  • Northwest Biotherapeutics, Inc. - Monotherapy Products in Pipeline, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Target, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Northwest Biotherapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2014
Back to Top